A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Oren Smaletz; Maria DPE Diz; Claudio C do Carmo; Jorge Sabbaga; Geraldo F Cunha-Junior; Sergio J Azevedo; Fernando C Maluf; Carlos H Barrios; Ronaldo L Costa; Ana G Fontana; Vivian Madrigal; Alberto J Wainstein; Fernanda P Yeda; Venancio A Alves; Ana M Moro; Roberto Blasbalg; Andrew M Scott; Eric W Hoffman

Journal article

A phase II trial with anti-Lewis-Y monoclonal antibody (hu3S193) for the treatment of platinum resistant/refractory ovarian, fallopian tube and primary peritoneal carcinoma

Oren Smaletz, Maria DPE Diz, Claudio C do Carmo, Jorge Sabbaga, Geraldo F Cunha-Junior, Sergio J Azevedo, Fernando C Maluf, Carlos H Barrios, Ronaldo L Costa, Ana G Fontana, Vivian Madrigal, Alberto J Wainstein, Fernanda P Yeda, Venancio A Alves, Ana M Moro, Roberto Blasbalg, Andrew M Scott, Eric W Hoffman

Gynecologic Oncology | ACADEMIC PRESS INC ELSEVIER SCIENCE | Published : 2015

DOI: 10.1016/j.ygyno.2015.05.023

University of Melbourne Researchers

Andrew Scott Author Medicine - Austin Health

Grants

Awarded by Fundo de Financiamento de Estudos de Projetos e Programas, Brazil (FINEP)

Funding Acknowledgements

This work was supported in part by a grant from Fundo de Financiamento de Estudos de Projetos e Programas, Brazil (FINEP) 01.06.0759.00 and 01.07.0096.00.